Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Recent insights into the mechanism of action of glatiramer acetate.
Neurotrophic and Neuroprotective effects of muscle contraction.
The Charcot Lecture | Beating MS: A story of B cells, with twists and turns.
A novel adaptive design strategy increases the efficiency of clinical trials in secondary progressive multiple sclerosis.
A pilot trial of Cop 1 in exacerbating-remitting multiple sclerosis.
Magnetic resonance imaging of myelin using ultrashort Echo time (UTE) pulse sequences: Phantom, specimen, volunteer and multiple sclerosis patient studies.
Pediatric Multiple Sclerosis.
The effects of diet on the severity of central nervous system disease: One part of lab-to-lab variability.
Differences in the burden of psychiatric comorbidity in MS vs the general population.
PML in a patient treated with dimethyl fumarate from a compounding pharmacy.
Cervical cord and ventricle affection in neuromyelitis optica.
Fingolimod modulates multiple neuroinflammatory markers in a mouse model of Alzheimer's disease.
The possible effects of the solar and geomagnetic activity on multiple sclerosis.
Sphingosine-1-Phosphate (S1P) Impacts Presynaptic Functions by Regulating Synapsin I Localization in the Presynaptic Compartment.
Persistence with and adherence to fingolimod compared with other disease-modifying therapies for the treatment of multiple sclerosis: a retrospective US claims database analysis.
Neurovascular coupling in patients with relapsing-remitting multiple sclerosis.
Fumaric acid esters promote neuronal survival upon ischemic stress through activation of the Nrf2 but not HIF-1 signaling pathway.
Gastro Effects Dog Oral MS Drug Tecfidera
A Combination Trial of Copaxone plus Estriol in Relapsing Remitting Multiple Sclerosis
Effect of disease-modifying drugs on cortical lesions and atrophy in relapsing-remitting multiple sclerosis.
Central nervous system neuroinflammatory disorders in Asian/Pacific regions.
Neurorehabilitation Topics in Patients with Multiple Sclerosis: From Outcome Measurements to Rehabilitation Interventions.
Decreased systemic IL-7 and soluble IL-7Rα in multiple sclerosis patients.
Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis.
Developing a Valuation Function for the Preference-Based Multiple Sclerosis Index: Comparison of Standard Gamble and Rating Scale.

Pages